HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tobias Dechow Selected Research

Bone Diseases (Bone Disease)

1/2017Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tobias Dechow Research Topics

Disease

13Neoplasms (Cancer)
03/2024 - 05/2008
8Multiple Myeloma
02/2022 - 10/2006
5Breast Neoplasms (Breast Cancer)
10/2023 - 01/2021
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 07/2010
4Lymphoma (Lymphomas)
01/2014 - 11/2008
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2013 - 06/2007
3Adenocarcinoma
03/2024 - 10/2022
3Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 01/2022
2Disease Progression
01/2022 - 01/2021
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2014 - 01/2013
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2014 - 10/2012
1Neoplasm Metastasis (Metastasis)
10/2023
1Anemia
01/2023
1Leukopenia
01/2023
1Adenocarcinoma of Lung
10/2022
1Carcinoma (Carcinomatosis)
11/2020
1Mucositis
11/2020
1Vomiting
01/2017
1Bone Diseases (Bone Disease)
01/2017
1Nausea
01/2017
1Paraproteinemias (Monoclonal Gammopathy)
12/2014
1Bites and Stings (Sting)
07/2012
1Squamous Cell Neoplasms (Squamous Cell Cancer)
08/2011
1Polyploidy
08/2011
1B-Cell Lymphoma (Lymphoma, B Cell)
05/2011
1Carcinogenesis
07/2010
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2010

Drug/Important Bio-Agent (IBA)

5ThymidineIBA
01/2014 - 05/2008
4Biomarkers (Surrogate Marker)IBA
08/2023 - 06/2014
4Glucose (Dextrose)FDA LinkGeneric
01/2014 - 05/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 06/2007
3Bortezomib (Velcade)FDA Link
02/2022 - 08/2007
3Dexamethasone (Maxidex)FDA LinkGeneric
02/2022 - 08/2007
3Rituximab (Mabthera)FDA Link
06/2014 - 06/2007
3Caspase 3 (Caspase-3)IBA
01/2014 - 11/2008
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2011 - 06/2007
2RamucirumabIBA
03/2024 - 06/2023
2Paclitaxel (Taxol)FDA LinkGeneric
06/2023 - 11/2020
2GlypicansIBA
01/2023 - 01/2022
2Carboplatin (JM8)FDA LinkGeneric
01/2023 - 11/2021
2130-nm albumin-bound paclitaxelIBA
01/2023 - 11/2021
2Immune Checkpoint InhibitorsIBA
10/2022 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2021
2Hormones (Hormone)IBA
01/2022 - 01/2021
2PlatinumIBA
11/2021 - 11/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 10/2006
2EverolimusFDA Link
11/2020 - 10/2012
2Lenalidomide (CC 5013)FDA Link
08/2020 - 03/2017
2Proteins (Proteins, Gene)FDA Link
12/2014 - 08/2011
2Anaplastic Lymphoma KinaseIBA
01/2014 - 10/2012
2alovudineIBA
01/2013 - 05/2011
2Cytotoxins (Cytolysins)IBA
01/2013 - 11/2008
2Prednisone (Sone)FDA LinkGeneric
05/2011 - 06/2007
2Vincristine (Oncovin)FDA LinkGeneric
05/2011 - 06/2007
1NivolumabIBA
03/2024
1Apolipoproteins MIBA
10/2023
1C-Reactive ProteinIBA
10/2023
1EnzymesIBA
10/2023
1ImmunosorbentsIBA
10/2023
1Leucovorin (Folinic Acid)FDA Link
06/2023
1Fluorouracil (Carac)FDA LinkGeneric
06/2023
1Irinotecan (Camptosar)FDA LinkGeneric
06/2023
1nintedanibIBA
10/2022
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2022
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
10/2022
1Docetaxel (Taxotere)FDA Link
10/2022
1Immunologic Factors (Immunomodulators)IBA
02/2022
1pomalidomideIBA
02/2022
1Syndecan-1 (Syndecan 1)IBA
01/2022
1SyndecansIBA
01/2022
1Proteoglycans (Proteoglycan)IBA
01/2022
1Aromatase InhibitorsIBA
01/2021
1Fulvestrant (Faslodex)FDA Link
01/2021
1CyclinsIBA
01/2021
1AntigensIBA
01/2018
1Monoclonal AntibodiesIBA
01/2018
1zolbetuximabIBA
01/2018
1Bendamustine HydrochlorideFDA Link
03/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2014
1TOR Serine-Threonine KinasesIBA
01/2014
18- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA
01/2014
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
10/2012
1Single-Chain AntibodiesIBA
07/2012
1Melphalan (Alkeran)FDA LinkGeneric
04/2012
1Cetuximab (Erbitux)FDA Link
08/2011
1Aurora KinasesIBA
08/2011
1ErbB Receptors (EGF Receptor)IBA
07/2010
1LigandsIBA
07/2010
1RFB4(dsFv)-PE38 recombinant immunotoxinIBA
01/2010
1Cytostatic AgentsIBA
06/2009
1Deoxyglucose (2 Deoxy D glucose)IBA
06/2009

Therapy/Procedure

16Therapeutics
03/2024 - 11/2008
12Drug Therapy (Chemotherapy)
03/2024 - 06/2007
1Combination Drug Therapy (Combination Chemotherapy)
03/2024
1Stem Cell Transplantation
01/2017
1Autologous Transplantation
11/2016
1Induction Chemotherapy
11/2016
1Operative Surgical Procedures
11/2010
1Immunotherapy
06/2007